Lyndra Therapeutics Funding: $146M Raised, Series B (2021)
Lyndra Therapeutics is based in Cambridge, MA. It has raised $146M in total funding. Latest round: Series B.
Lyndra Therapeutics funding overview
Lyndra Therapeutics is based in Cambridge, MA. Lyndra Therapeutics has raised $146M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in June 2021. The round record for Lyndra Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Bill & Melinda Gates Foundation, Gilead Sciences, Polaris, AIG Investments, Allergan. 5 distinct backers are named across the disclosed rounds.
Frequently asked about Lyndra Therapeutics funding
How much has Lyndra Therapeutics raised?
Lyndra Therapeutics has raised $146M in total disclosed funding across the rounds on record.
Who has invested in Lyndra Therapeutics?
Bill & Melinda Gates Foundation, Gilead Sciences, Polaris, AIG Investments, Allergan are named among the investors backing Lyndra Therapeutics.
What was the latest Lyndra Therapeutics funding round?
The most recent disclosed round is a Series B, announced in June 2021.
Where is Lyndra Therapeutics based?
Lyndra Therapeutics is based in Cambridge, MA.
When did Lyndra Therapeutics last raise?
The last disclosed Lyndra Therapeutics round closed in June 2021 at Series B.
Totals shown for Lyndra Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
